Abstract
Recently,1 an attempt has been made to subdivide and classify the hallucinogens as follows:
-
1.
Visionary psychodysleptics (e.g., LSD, mescaline, DMT). These produce prominently perceptual distortions and hallucinations, emotional changes, and changes in thinking.
-
2.
Imagery-producing psychodysleptics (e.g., cannabis). These potentiate visual imagery and produce time, body-image, and thought distortion.
-
3.
Trance-producing psychodysleptics [e.g., lysergic acid amide from Rivea corymbosa (ololiquhqui)].
-
4.
Deliriants (e.g., atropine).
-
5.
Neurotoxic psychodysleptics (e.g., lupenine) with an addition of motor, vegetative, and peripheral nervous system effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Diaz, J. L., 1967, Anna. Rev. Pharmacol. Toxicol. 17: 647–675.
Brown, W. M., Keller, W. J., and Bonfiglio, J. F., 1979, Life Sci. 25: 1043–1054.
Kantor, R. E., Dudletter. S. D., and Shulgin, A. T., 1980, Biol. Psychiatry 15: 349–352.
Brown, W. M., Keller, W. J., and Bonfiglio, J. F., 1978, Life Sci. 23: 1175–1184.
Hempill, R. E., 1981, S. Afr. Med. J. 59: 96.
Aghajanian, G. K., Haigler, H. J., and Bloom, F. E., 1972, Life Sci. 11:615–622. 6a.de Montigny. C., and Aghajanian, G. K., 1977, Neuropharmacology 16: 811–818.
Briggs, I., 1977, J. Physiol. (Loud.) 265: 327–340.
Aghajanian, G. K., 1980, Brain Res. 186: 492–498.
a.Rogawski, M. A., and Aghajanian, G. K., 1979, Life Sci. 24: 1289–1298.
McCall, R. B., and Aghajanian, G. K., 1980, Life Sci. 26: 1149–1156.
Geyer, M. A., 1978, Life Sci. 26: 431–434.
Friedman, E., Lambert, G. A., and Buchweitz, E., 1978, Eur. J. Pharmacol. 49: 157–161.
Hayes, R. L., Newton, P. G., Rosecrans, J. A., and Mayer, D. J., 1977, Brain Res. 122: 367–372.
Lee, E. H. Y., and Geyer, M. A., 1980, Neuropharmacology 19: 1005–1007.
Peters, D. A. V., and Tany, 1977, Biochem. Pharmacol. 26: 1085–1086.
Marini, J. L., Jacobs, B. L., Sheard, M. H., and Trulson, M. E., 1981, Psychopharmacology 73: 328–331.
Sloviter, R. S., Drust, E. G., Damiano, B. P., and Connor, J. D., 1980, J. Pharmacol. Exp. Ther. 214: 231–238.
Stroll, D. M., Gorelick, D. A., Bozewicz, T., Bridger, W. H., Gillin, J. C.. and Wyatt, R.. J., 1978, Psychopharmacologia 17: 1035–1040.
Smythies, J. R., Sykes, E. A., and Lord, C. P., 1966, Psychopharmacologia 9: 434–446.
Winter, J. C., 1978, J. Pharmacol. Exp. Ther. 204: 416–423.
Glennon, R. A., Rosecrans, J. A., Young, R., and Gaines, J.. 1979, Life Sci. 24: 993–998.
Kuhn, D. M., White, F. J., and Appel, J. B., 1978, Neuropharmacology 17: 257–263.
Prozialeck, W. C., and Vogel, W. H., 1979, Psychopharmacology 60: 209–310.
Colpaert, F. C., Niemegeers, C. J. E., and Janssen, P. A. J., 1979, Eur. J. Pharmacol. 58: 525–529.
Fuxe, K., Agnati, L. F., Con-odi, H., Everitt, B. J., Hokfelt, T., Lofstrom, A., and Ungersteat, U., 1975, Adv. Neurol. 9: 223–242.
Menon, M. K., Clark, W. G., and Masuoka, D. T., 1977, Psychopharmacology 52: 291–297.
Persson, S.-A., 1978, Life Sci. 23: 523–526.
Persson, S.-A., and Johansson, H., 1978, Brain Res. 142: 505–513.
Pieri, L., Keller, H. H., Burkard, W., and Da Prada, M., 1978, Nature 272: 278–279.
Meltzer, H. Y., Fessier, R. G., Simonovic, M., Doherty, J., and Fang, V. S., 1977. Psycho-pharmacology 54: 39–44.
Meltzer, H. Y., Fessier, R. G.. Simonovic, M., Doherty. J., and Fang, V. S., 1977, Psycho-pharmacology 54: 39–44.
Meltzer, H. Y., Fessier, R. G., Simonovic, M., and Fang, V. S., 1978, Psychopharmacology 56: 255–259.
Meltzer, H. Y., Fessier, R. G., Simonovic, M., and Fang, V. S., 1978, Life Sci. 23: 1185–1192.
Trulson, M. E., and Jacobs. B. L., 1979, Eur. J. Pharmacol. 54: 43–50.
Fillion, G., Fillion, M. P., Jacob, J., and Rouselle, J. C., 1976, Br. J. Pharmacol. 58: 425P - 426 P.
Whittaker, P. M., and Seeman, P., 1978, Psychopharmacology 59: 1–5.
Drummond, A. H., Bucher, F., and Levitan, I. B., 1970, J. Biol. Chem. 255: 6679–6686.
Drummond, A. H., Bucher, F., and Levitan, I. B., 1980, Brain Res. 184: 163–177.
Trulson, M. E., and Jacobs, B. L., 1979, Life Sci. 24: 2053–2062.
Glennon, R. A., Liebowitz, S. M., and Mack, E. C., 1978, J. Med. Chem. 21: 822–825.
Gtennon, R. A., Liebowitz, S. M., and Anderson, G. M. III, 1980, J. Med. Chem. 23: 294–299.
Glennon, R. A., Liebowitz, S. M., and Leming-Doot, D., 1980, J. Med. Chem. 23: 990–994.
Burt, D. R., Creese, I., and Snyder, S. H., 1976, Mol. Pharmacol. 12: 631–638.
Drummond, A. H., Bucher, F., and Levitan, I. B., 1978, Nature 272: 368–370.
Whittaker, P. M., and Seeman, P., 1977, J. Pharm. Pharmacol. 29: 506–507.
Christoph, G. R.. Kuhn, D. M., and Jacobs, B. C., 1977, Life Sci. 21: 1585–1596.
Christoph, G. R., Kuhn, D. M., and Jacobs, B. L., 1978, Life Sci. 23: 2099–2110.
Creese, I., Burt, D. R., and Snyder, S. H., 1975, Life Sci. 17: 1715–1720.
Ahn, H. S., and Makman, M. H., 1979, Brain Res. 162: 77–88.
Nozaki, M., Vanpel, D. B., and Martin, W. R., 1977, Eur. J. Pharmacol. 46: 339–349.
Rose, D., and Horn, G., 1977, Exp. Brain Res. 27: 71–80.
Fox, P. C., and Dray, A., 1979, Brain Res. 161: 167–172.
Dray, A., Fox, P. C., Hilary, M., and Somjer, G. G., 1980, Brain Res. 200: 105–121.
Moore, R. H., Hatada, K., and Dommio, E. F., 1976, Neuropharmacology 15: 535–539.
Trulson, M. E., and Jacobs, B. L., 1979, Science 205: 515–510.
Whittaker, P. M., and Seeman, P., 1978, Proc. Natl. Acad. Sci. U.S.A. 75: 5783–5787.
Dolphin, A., Enjalbert, A., Tassin, J.-P., Lucas, M., and Bockaert, J., 1978, Life Sci. 22:345352.
Frederickson, P. A., and Richelson, E., 1979, Eur. J. Pharmacol. 56: 261–264.
Hanbrich, D. R., and Wang, P. F. L., 1977, Brain Res. 131: 158–161.
Wong, Y.-W., Chiu, S., and Mishra, R. K., 1979, Biochem. Pharmacol. 18: 2207–2209.
Fertziger, A. P., and Fischer, R., 1977, Psychopharmacology 54: 313–314.
Commissaris, R. L., Moore, K. E., and Rech, R. H., 1980, Pharmacol. Biochem. Behay. 13: 601–607.
Barker, S. A., Monti, J. A., and Christian, S. T., 1980, Biochem. Pharmacol. 29: 1049–1057.
Stramentinoli, G., and Baldessarini, R. J.. 1978, J. Neurochem. 31: 1015–1020.
Kelsoe, J. R., Tolbert, L. C., Crews, E. L., and Symthies, J. R., 1982, J. Neurosci. Res. 8: 99–103
Sangiah, S., Gomez, M. V., and Domino, E. F., 1979, Biol. Psychiatry 14: 925–936.
Heikkila, J. J., Holbrook, L., and Brown, I. R., 1979, J. Neurochem. 32: 1793–1799.
Holbrook, L., and Brown, I., 1977, Life Sci. 21: 1037–1044.
Datta, R. K., Antopol, W., and Ghosh, J. J., 1971, Biochem. J. 125: 213–219.
Domelsmith, L. N., Munchangen, L. L., and Houk, K. N., 1977, J. Med. Chem. 20: 1346–1348.
Glennon, R. A., and Gessner, P. K., 1977, Res. Commun. Chem. Pathol. Pharmacol. 18: 453–465.
Sissors, D. L., and Voss, E. W., Jr., 1978, Biochem. Pharmacol. 27: 2705–2711.
Paul, S. M., Halaris, A. E., Freedman, D. X., and Hsu, L. L., 1976, J. Neurochem. 27: 625–627.
Glennon, R. A., Schubert, E., Jacyno, J. M., and Rosecrans, J. A., 1980, J. Med. Chem. 23: 1222–1226.
Vogel, W. H., and Evans, B. D., 1977, Life Sci. 20: 1629–1636.
Symthies, J. R., Morin, R. D., and Brown, G. B., 1979, Biol. Psychiatry 14: 549–556.
Corbett, L., Christian, S. T., Benington, F., Smythies, J. R., and Morin, R. D., 1978, Br. J. Psychiatry 132: 139–144.
Murray, R. M., Oon, M. C. H., Rodnight, R., Birley, J. L. T., and Smith, A., 1979, Arch. Gen. Psychiatry 36: 644–649.
Haskovec, L., Jindrova, O., Krulik, R., and Paulovsky, P., 1981, Proceedings Illyd International Congress of Biological Psychiatry.
Checkley, S. A., Oon, M. C. H., Rodnight, R., Murphy, M. P., Williams, R. S., and Birley, J. L. T., 1979, Am. J. Psychiatry 136: 439–441.
Mehl, E., and Guiard, L., 1978, Hoppe Seylers Z. Physiol. Chem. 359: 539–541.
Barker, S. A., Harrison, R. E. W., Monti, J. A., Brown, G. B., and Christian, S. T., 1981, Biochem. Pharmacol. 30: 9–17.
Rommelspacher, H., and Subramanian, N., 1979, Ear. J. Pharmacol. 56: 81–86.
Bosin, T. R., and Beck, O., 1979, J. Neurochem. 32: 1853–1855.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Smythies, J.R. (1985). Hallucinogens. In: Lajtha, A. (eds) Alterations of Metabolites in the Nervous System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6740-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6740-7_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6742-1
Online ISBN: 978-1-4757-6740-7
eBook Packages: Springer Book Archive